Table 2.

Results of the Tests for Assessing the Comprehension of Metaphoric Speech, Verbal Ability (LPS 1 + 2, 5, 6), and Concentration (CPT) in Women With Schizophrenia (n = 19) Under Active Drug (Estrogen Replacement) and Placebo Conditions—Mean Values and SDs (M ± SD); Differences Between Active Drug and Placebo Conditions, and the Effect of Time (Practice Effect) Were Calculated by Means of Random-Effect Regression Analysis

Tests	Active Drug	Placebo	P
Abstract priming (ms)	60.6 ± 95.53	−7.1 ± 108.5	.013
Concrete priming (ms)	65.4 ± 170.0	34.4 ± 142.0	.400
LPS 1 + 2 (verbal factor)	37.9 ± 17.9	39.3 ± 16.9	.294
LPS 5 (word recognition)	20.2 ± 11.1	18.4 ± 10.7	.253
LPS 6 (word fluency)	31.9 ± 11.5	32.8 ± 10.4	.450
CPT (d-prime index)	4.87 ± 1.25	4.57 ± 1.40	.149

Note: LPS, Leistungsprüfsystem; CPT, Continuous Performance Test.

The P values in the table are the results of Wald tests of the drug effect.